1. Home
  2. PROV vs ACOG Comparison

PROV vs ACOG Comparison

Compare PROV & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

HOLD

Current Price

$17.08

Market Cap

106.0M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$7.00

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
ACOG
Founded
1956
2000
Country
United States
Canada
Employees
N/A
57
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
106.0M
110.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
PROV
ACOG
Price
$17.08
$7.00
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$16.25
$16.00
AVG Volume (30 Days)
6.1K
31.1K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
N/A
N/A
Revenue This Year
$4.14
$139.22
Revenue Next Year
$3.70
$134.48
P/E Ratio
$25.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.95
$4.50
52 Week High
$17.42
$10.88

Technical Indicators

Market Signals
Indicator
PROV
ACOG
Relative Strength Index (RSI) 57.34 69.57
Support Level $16.91 $6.46
Resistance Level $17.38 $7.69
Average True Range (ATR) 0.28 0.36
MACD 0.01 0.10
Stochastic Oscillator 78.26 99.50

Price Performance

Historical Comparison
PROV
ACOG

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: